Healthcare provider profile · identity verified

Dina Faig Ibrahim, M.D.

Family Practice · SOUTHFIELD, MI · NPI 1134412679

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	595	190
Amlodipine Besylate	Amlodipine Besylate	396	126
Duloxetine Hcl	Duloxetine Hcl	339	120
Losartan Potassium	Losartan Potassium	266	89
Omeprazole	Omeprazole	250	100
Rosuvastatin Calcium	Rosuvastatin Calcium	250	87
Levothyroxine Sodium	Levothyroxine Sodium	244	66
Metformin Hcl	Metformin Hcl	229	76
Nifedipine Er	Nifedipine	188	63
Lisinopril	Lisinopril	180	62
Potassium Chloride	Potassium Chloride	170	60
Simvastatin	Simvastatin	168	49
Gabapentin	Gabapentin	164	68
Spironolactone	Spironolactone	148	50
Metoprolol Succinate	Metoprolol Succinate	133	41
Hydrochlorothiazide	Hydrochlorothiazide	123	38
Ozempic	Semaglutide	121	31
Carvedilol	Carvedilol	116	41
Trazodone Hcl	Trazodone Hcl	114	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	111	34
Furosemide	Furosemide	110	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	105	38
Famotidine	Famotidine	103	45
Fluticasone Propionate	Fluticasone Propionate	101	49
Pantoprazole Sodium	Pantoprazole Sodium	100	39
Tamsulosin Hcl	Tamsulosin Hcl	96	38
Metoprolol Tartrate	Metoprolol Tartrate	92	38
Trulicity	Dulaglutide	82	25
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	80	80
Hydralazine Hcl	Hydralazine Hcl	74	25
Jardiance	Empagliflozin	74	27
Albuterol Sulfate Hfa	Albuterol Sulfate	73	30
Ipratropium Bromide	Ipratropium Bromide	62	35
Chlorthalidone	Chlorthalidone	61	22
Glipizide	Glipizide	61	22
Diclofenac Sodium	Diclofenac Sodium	59	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	20
Allopurinol	Allopurinol	56	20
Atenolol	Atenolol	55	21
Ammonium Lactate	Ammonium Lactate	53	20
Alendronate Sodium	Alendronate Sodium	49	21
Acetaminophen-Codeine	Acetaminophen With Codeine	48	15
Glimepiride	Glimepiride	48	15
Eliquis	Apixaban	46	19
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	46	20
Meloxicam	Meloxicam	45	26
Metformin Hcl Er	Metformin Hcl	44	15
Triamcinolone Acetonide	Triamcinolone Acetonide	40	23
Hydroxyzine Hcl	Hydroxyzine Hcl	38	16
Ibuprofen	Ibuprofen	38	14
Clopidogrel	Clopidogrel Bisulfate	37	11
Januvia	Sitagliptin Phosphate	37	13
Labetalol Hcl	Labetalol Hcl	37	suppressed
Lidocaine	Lidocaine	37	17
Vitamin D2	Ergocalciferol (Vitamin D2)	37	13
Doxazosin Mesylate	Doxazosin Mesylate	36	11
Nortriptyline Hcl	Nortriptyline Hcl	36	12
Tizanidine Hcl	Tizanidine Hcl	36	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	11
Klor-Con M20	Potassium Chloride	35	14
Montelukast Sodium	Montelukast Sodium	35	15
Pravastatin Sodium	Pravastatin Sodium	35	13
Donepezil Hcl	Donepezil Hcl	34	suppressed
Ketoconazole	Ketoconazole	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Terbinafine Hcl	Terbinafine Hcl	31	15
Acyclovir	Acyclovir	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	13
Clonidine Hcl	Clonidine Hcl	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Bumetanide	Bumetanide	27	suppressed
Prednisone	Prednisone	27	19
Shingrix	Varicella-Zoster Ge/As01b/Pf	27	24
Tolterodine Tartrate Er	Tolterodine Tartrate	27	suppressed
Hydrocortisone	Hydrocortisone	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	12
Glipizide Er	Glipizide	24	suppressed
Methocarbamol	Methocarbamol	24	12
Tenivac	Tetanus-Diphtheria Toxoids/Pf	23	23
Ventolin Hfa	Albuterol Sulfate	23	15
Alprazolam	Alprazolam	22	15
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Xarelto	Rivaroxaban	21	suppressed
Epinephrine	Epinephrine	20	15
Levetiracetam	Levetiracetam	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Naproxen	Naproxen	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	16
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Nystatin	Nystatin	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Desonide	Desonide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Fluconazole	Fluconazole	11	11
Folic Acid	Folic Acid	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error